Page 5 - Heart Failure Guidelines
P. 5
Pediatric Heart Failure Guidelines
Medical Management Chemotherapy Induced Cardiomyopathy ............................................25
Follow-up Schedule for Chemotherapy Induced Cardiomyopathy ..........................................25
Neuromuscular Disorder Associated Cardiomyopathy ..............................................................26
Additional Evaluation for Patient with Neuromuscular Disorder associated Cardiomyopathy .26
Introduction ...............................................................................................................................26
Initial Evaluation ........................................................................................................................26
Ongoing Management ...............................................................................................................26
Dose escalation plan (outpatient monitoring) .........................................................................27
Imaging .....................................................................................................................................28
Arrhythmia Screening ................................................................................................................28
Advanced Therapies .................................................................................................................28
Myocarditis ................................................................................................................................29
Additional Evaluation for possible Myocarditis .......................................................................29
Medical Management Myocarditis .........................................................................................29
Immunotherapy Management Myocarditis .............................................................................29
Follow-up Schedule for Myocarditis .......................................................................................30
Medication Doses .....................................................................................................................31
Anticoagulation Schedules ........................................................................................................33
Updated 7/31/2018 page 5
